MDS: Clinical Trials

2 trials for MDS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow MDS: new trials by email Literature Review of MDS trials Research Report on MDS

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
rigosertib, Any approved or standard-of-care therapy, best supportive care (BSC) - Myelodysplastic Syndrome, MDS
Phase 3TerminatedTraws Pharma, Inc.3722015-12-022022-09-26
Stem Cell Transplantation for Hematological Malignancies
Stem Cell Transplant, Busulfan, Cyclophosphamide - Leukemia, Lymphocytic, Acute, AML
Phase 2 / Phase 3TerminatedMasonic Cancer Center, University of Minnesota112000-06-072017-12-05

Narrower conditions

Anemia, Refractory, with Excess of Blasts (1)  ·  Hematologic Neoplasms (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Bone Marrow Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Interventions

Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Melphalan (1)  ·  ON 01910 (1)  ·  Stem Cell Transplantation (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)  ·  Traws Pharma, Inc. (1)

Countries

United States (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Margaret MacMillan, MD (1)  ·  Steven M. Fruchtman, MD (1)

NIH funding

2015 (1)